Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood plasma for the manufacture of its products. ADMA's ...

Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood plasma for the manufacture of its products. ADMA's mission ...

ADMA Biologics, Inc. 1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue (1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 ...

RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported first-quarter net income of $26.9 million. The Ramsey, New Jersey-based company said it had profit of ...

Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood plasma for the manufacture of its products. ADMA's ...

Indeed, not everything was perfect for ADMA back in 2021, and there were certainly uncertainties that could have made investors apprehensive about driving the share price higher. However ...

ADMA Biologics ADMA will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement. Analysts anticipate ADMA Biologics to ...

ADMA Biologics reports 1Q 2025 total revenue of $114.8 million, marking a 40% increase year-over-year. ADMA Biologics, Inc. reported strong financial results for the first quarter of 2025, with ...

Good afternoon and welcome to the ADMA Biologics First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 7, 2025. At this time, all participants are in a listen ...